Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-Year Results From Two Phase 3 Studies. J of Skin 2024, 8 (6), s435. https://doi.org/10.25251/skin.8.supp.435.